Unmatched Productivity and Seamless Scalability:
Advantages of the XCell® ATF System for
Upstream Process Intensification
Muhammad Shamim is a seasoned biopharmaceutical processing expert specializing in cell and gene therapy, AAV transfection, and monoclonal antibody processes. He currently serves as a dedicated field applications scientist for upstream products at Repligen Corporation, where he provides advanced implementation and technical support for the XCell® ATF System and KrosFlo® TFDF® System. Muhammad's expertise has been honed through comprehensive education and practical application, making him a vital asset in optimizing bioprocessing operations. He has a master's degree in biopharmaceutical processing from the Keck Graduate Institute and led MSAT/PD projects in a number of biotherapeutic companies prior to joining Repligen. His commitment to advancing the industry and supporting clients underscores his significant contribution to the realm of biopharmaceutical processing.
Click the link below to view the Dare to Innovate: Across the Bioprocess Workflow series page.